- Conditions
- Otitis Media
- Interventions
- Tube Delivery System (TDS)
- Device
- Lead sponsor
- Integra LifeSciences Corporation
- Industry
- Eligibility
- 6 Months to 21 Years
- Enrollment
- 70 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2012
- U.S. locations
- 1
- States / cities
- Port Saint Lucie, Florida
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 49–61
of 61
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Otitis Media, Middle Ear Effusion
- Interventions
- Insertion of tympanostomy tubes
- Procedure
- Lead sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- NIH
- Eligibility
- 0 Years to 61 Days
- Enrollment
- 400 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2002 – 2005
- U.S. locations
- 1
- States / cities
- Pittsburgh, Pennsylvania
- Conditions
- Otitis Media in Patients With Tympanostomy Tubes
- Interventions
- Ciprofloxacin 0.3%/dexamethasone 0.1% sterile otic suspension, CIPRODEX® (ciprofloxacin 0.3%/dexamethasone 0.1%), Placebo Sterile Otic Suspension
- Drug
- Lead sponsor
- Par Pharmaceutical, Inc.
- Industry
- Eligibility
- 6 Months to 12 Years
- Enrollment
- 203 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2015
- U.S. locations
- 23
- States / cities
- Birmingham, Alabama • Mesa, Arizona • Phoenix, Arizona + 17 more
- Conditions
- Otitis Media
- Interventions
- dornase alfa (Pulmozyme®)
- Drug
- Lead sponsor
- University of Colorado, Denver
- Other
- Eligibility
- 1 Year to 18 Years
- Enrollment
- 41 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2007 – 2011
- U.S. locations
- 1
- States / cities
- Denver, Colorado
- Conditions
- Tympanic Membrane Perforation
- Interventions
- Eustachian tube function testing
- Other
- Lead sponsor
- University of Pittsburgh
- Other
- Eligibility
- 3 Years to 16 Years
- Enrollment
- 19 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2017
- U.S. locations
- 1
- States / cities
- Pittsburgh, Pennsylvania
- Conditions
- Middle Ear Effusion, Otitis Media
- Interventions
- Laser otoscope examination
- Device
- Lead sponsor
- MSTATT LLC
- Industry
- Eligibility
- 6 Months to 18 Years
- Enrollment
- 150 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026
- U.S. locations
- 1
- States / cities
- Cleveland, Ohio
- Conditions
- Effect of Drug, Complication of Treatment
- Interventions
- Dexmedetomidine
- Other
- Lead sponsor
- Nemours Children's Clinic
- Other
- Eligibility
- 6 Months to 5 Years
- Enrollment
- 276 participants
- Timeline
- 2022 – 2023
- U.S. locations
- 1
- States / cities
- Wilmington, Delaware
- Conditions
- Otitis Media With Effusion, Acute Otitis Media, Otitis Media
- Interventions
- Iontophoresis and tube placement
- Combination Product
- Lead sponsor
- Smith & Nephew, Inc.
- Industry
- Eligibility
- 6 Months to 17 Years
- Enrollment
- 200 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2027
- U.S. locations
- 6
- States / cities
- Louisville, Kentucky • Cherry Hill, New Jersey • New Brunswick, New Jersey + 3 more
- Conditions
- Otitis Media With Effusion, Acute Otitis Media
- Interventions
- tympanostomy tube
- Device
- Lead sponsor
- Integra LifeSciences Corporation
- Industry
- Eligibility
- 6 Months and older
- Enrollment
- 53 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010
- U.S. locations
- 4
- States / cities
- Port Saint Lucie, Florida • Louisville, Kentucky • San Antonio, Texas + 1 more
- Conditions
- Otitis Media, Otitis Media Effusion, Otitis Media Recurrent, Otitis Media With Effusion in Children, Otitis Media Chronic, Otitis Media in Children, Tympanostomy Tube Insertion, Osteopathic Manipulative Treatment (OMT)
- Interventions
- Experimental Osteopathic Manipulative Treatment (OMT) Protocol, Control Osteopathic Manipulative Treatment (OMT) Protocol
- Other
- Lead sponsor
- Sarah Vidal
- Other
- Eligibility
- 6 Months to 6 Years
- Enrollment
- 200 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2028
- U.S. locations
- 2
- States / cities
- Lynchburg, Virginia
- Conditions
- Otitis Media in Children, Chronic Otitis Media With Effusion, Recurrent Acute Otitis Media
- Interventions
- Tympanostomy tube
- Device
- Lead sponsor
- David Chi, MD
- Other
- Eligibility
- 6 Months to 14 Years
- Enrollment
- 386 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2028
- U.S. locations
- 2
- States / cities
- Pittsburgh, Pennsylvania • Sewickley, Pennsylvania
- Conditions
- Bilateral Middle Ear Effusion Requiring Tympanostomy Tube Placement
- Interventions
- OTO-201, Placebo, Sham
- Drug
- Lead sponsor
- Otonomy, Inc.
- Industry
- Eligibility
- 6 Months to 12 Years
- Enrollment
- 83 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2013
- U.S. locations
- 1
- States / cities
- San Diego, California
- Conditions
- Pain, Postoperative, Otitis Media
- Interventions
- Ketorolac, Fentanyl
- Drug
- Lead sponsor
- Anica Crnkovic
- Other
- Eligibility
- 8 Months to 7 Years
- Enrollment
- 150 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2022
- U.S. locations
- 1
- States / cities
- Albany, New York